ARJUN TARAKAD to Double-Blind Method
This is a "connection" page, showing publications ARJUN TARAKAD has written about Double-Blind Method.
Connection Strength
0.041
-
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2024 01; 23(1):37-45.
Score: 0.041